Clinical Trial

Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers

Active, Not Recruiting

Summary

Approximately 42% of American adults are obese, and this condition is strongly related to the development of colorectal cancer. Innovative lifestyle strategies to treat obesity and reduce colorectal cancer risk are critically needed. This research will demonstrate that time-restricted eating, a type of intermittent fasting, is an effective therapy to help obese individuals reduce and control their body weight and prevent the development of colorectal cancer.

Protocol Amendment History 4 changes

notable Primary completion moved earlier: 2027-08-31 -> 2027-03-31 2026-07-22

minor Completion moved earlier: 2027-09-30 -> 2027-03-31 2026-07-22

notable Primary completion pushed: 2027-03-31 -> 2027-08-31 2026-07-21

minor Completion pushed: 2027-03-31 -> 2027-09-30 2026-07-21

Trial Details

NCT Number	NCT05114798
Lead Sponsor	University of Illinois at Chicago Collaborators: National Cancer Institute (NCI)
Conditions	Time Restricted Eating, Obesity, Weight Loss, Colorectal Cancer
Enrollment	194 participants
Start Date	2022-05-17
Primary Completion	2027-03-31 (estimated)
Study Completion	2027-03-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-21